ResearcherFirst Affiliated Hospital of Anhui Medical UniversityActive in the last 2 years

Yeben Qian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2061-423X; OpenAlex author ID A5029266541. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Association of LAMA3 expression with perineural invasion and chemoresistance in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s12672-025-03971-5 ↗
Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinoma. Last author DOI 10.3389/fcell.2022.901207 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yang Yang · 1 shared paper, 2025 · strength 0.33
- Paper Association of LAMA3 expression with perineural invasion and chemoresistance in pancreatic ductal adenocarcinoma. DOI 10.1007/s12672-025-03971-5 ↗
Hao Chen · 1 shared paper, 2022 · strength 0.20
- Paper Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in… DOI 10.3389/fcell.2022.901207 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.